Company: HROW
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009263
Chunk: 37

Company: HARROW, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 37
---
2025,
there is no unrecognized compensation expense related to unvested PSUs. The stock-based compensation for PSUs during the three months
ended March 31, 2025 and 2024 was $3,638,000.

     21 

Stock-Based Compensation Summary

The Company recorded stock-based compensation
related to equity instruments granted to employees, directors and consultants as follows:

 SCHEDULE OF STOCK BASED COMPENSATION GRANTED TO EMPLOYEES, DIRECTORS AND CONSULTANTS

    2025  
    2024 

    For the Three Months
                                                                               Ended March 31, 

    2025  
    2024 
  
    Employees - selling, general and administrative 
    $3,794,000  
    $3,525,000 
  
    Employees – research and development 
     422,000  
     439,000 
  
    Directors - selling, general and administrative 
     226,000  
     188,000 
  
    Consultants - selling, general and administrative 
     114,000  
     17,000 
  
    Total 
    $4,556,000  
    $4,169,000 

NOTE 13. COMMITMENTS AND CONTINGENCIES

Legal

General and Other

In the ordinary course of business, the Company
is involved in various legal proceedings, government investigations and other matters that are complex in nature and have outcomes that
are difficult to predict. The Company describes legal proceedings and other matters that are/were significant or that it believes could
become significant in this footnote.

The Company records accruals for loss contingencies
to the extent that it concludes it is probable that a liability has been incurred and the amount of the related loss can be reasonably
estimated. The Company evaluates, on a quarterly basis, developments in legal proceedings and other matters that could cause an increase
or decrease in the amount of a liability that has been accrued previously.

The Company’s legal proceedings involve
various aspects of its business and a variety of claims, some of which present novel factual allegations and/or unique legal theories.
Typically, a number of the matters pending against the Company are at early stages of the legal process, which in complex proceedings
of the sort the Company faces often extend for several years. While it is not possible to accurately predict or determine the eventual
outcomes of matters that have not concluded, an adverse determination in one or more